The Royal (Dick) School of Veterinary Studies has become the first place in the UK to offer reptile training recognised by the European College of Zoological Medicine.
Kevin Eatwell, who is part of the School's Exotic Animal and Wildlife Service, has been awarded diplomat status by the European College of Zoological Medicine (ECZM).
This will enable him to offer training to residents at the School wishing to gain European accreditation in the area of herpetology, which covers reptiles.
The Royal (Dick) School of Veterinary Studies, which is part of the University of Edinburgh, also gained the endorsement of the ECZM to train residents to treat reptiles following a visit by its president.
The diplomat status recognises Mr Eatwell as a specialist in Europe. In addition, he is also one of only two RCVS diploma holders in reptile medicine in the UK.
To qualify as an ECZM diplomat a vet needs to meet stringent criteria. This includes the time spent specialising in a particular field as well as three first author and a minimum of three second co-author publications relevant to the specialty.
Many of Mr Eatwell's scientific papers followed on from a dissertation, which was funded through an educational grant through the RCVS Trust.
As a diplomat for the European College of Zoological Medicine, Mr Eatwell will input into the ECZM training criteria for vets specialising in the care and treatment of reptiles.
Mr Eatwell said: "I am delighted to have achieved such status by the European College of Zoological Medicine. It is very exciting to be involved in the education of specialist veterinary surgeons throughout Europe. This will also open the door for residents at the Royal (Dick) School of Veterinary Studies to obtain European qualifications relating to the specialist treatment of reptiles."
Mr Eatwell is one of only a handful of ECZM diplomats in the UK and the first in herpetology. Other ECZM diplomats cover disciplines including avian, small mammals and wildlife and conservation.
Cherry Bushell, Director of the RCVS Trust, said: "It's always wonderful to hear that the grants awarded by RCVS Trust do help make a difference to young vets and to the development of animal care in the UK and overseas. We congratulate Kevin on his achievement and wish him every success in the future."
The Royal (Dick) School of Veterinary Studies also has the UK's first European resident in Small Mammal Medicine, Elisabetta Mancinelli, who is being supervised by Anna Meredith, head of the Exotic Animal and Wildlife Service.
The BVA has announced that from 2013, its annual Congress will take place at the London Vet Show.
The association says that the move is being done to bring together political debate and clinical CPD on a large scale and to ensure that the BVA can reach an even wider audience with its representative and educational services.
The BVA and the Vet Show teamed up last year at London Vet Show 2011 to announce the launch of the BVA Careers Fair, which will be hosted at this year's London Vet Show on 15-16 November, and the start of a partnership that would ensure discounted Vet Show rates for BVA members.
2013 will also see two new clinical streams added to the London Vet Show programme creating a comprehensive CPD event for vets in small and mixed practice. Cattle and equine streams for mixed practitioners will be delivered by the BVA to run alongside the popular companion animal stream provided by the Royal Veterinary College.
The partnership will also see substantial discounts being offered to BVA members.
BVA President Carl Padgett said: "BVA's number one value is that our members are at the heart of everything we do. We know that members require good value, high quality and relevant CPD and we believe that our new partnership with the London Vet Show offers the best opportunity for us to provide members with exactly what they want.
"It's a significant move for BVA but one that makes complete sense. From 2013 we will be bringing together the contentious issue streams that are the bedrock of BVA Congress, with a high quality clinical CPD programme covering large and small animals, and one of the biggest and best veterinary exhibitions.
"We know we haven't attracted the delegate numbers we would like to have done in recent years and by partnering with the London Vet Show we have the opportunity to reach a much greater audience. It's a very exciting step forward for BVA."
Rob Chapman, Event Director for the London Vet Show, said: "We are all delighted to be developing our relationship with the BVA. To be able to host such an established and prestigious event as the BVA Congress at the London Vet Show is an honour for the Vet Show.
"Combining the long-standing history of the BVA with the rapidly developing reputation of the Vet Show gives us a great symbiotic relationship. The new clinical content that we will be working on together will help the event and that relationship even further offering great value for both Vet Show delegates and BVA members."
Greater collaboration between disciplines to promote the 'One Health' approach for people and pets could save the NHS 2.5 billion a year, according to Danny Mills, Professor of Veterinary Behavioural Medicine at the University of Lincoln.
Professor Mills, an authority on companion animal behaviour, cognition and welfare, made the claim at Purina’s 'Better with Pets' European Forum in Brussels, where experts in the animal and human relationship gathered recently to discuss the benefits that pets can have to public health.
Professor Mills highlighted how animal assisted activities and therapy (AAT), where animals are used to improve social, emotional and cognitive functioning, supporting recovery and rehabilitation, can play an important role in the cost saving. He also noted how pets have been shown to reduce anxiety in those with autism, while also easing the stress levels of parents and carers.
Attendees at the event heard an example of AAT in practice at the Sant Joan de Déu-Barcelona hospital in Spain where a functional unit has been in operation for the past six years. Here, sick children receive AAT on the advice of a doctor, both in the emergency room and on an inpatient basis. The hospital reports that the dogs help the children to have a better life and cope more effectively with their illnesses. Purina called on the public health community to recognise the advantages of AAT and to play an active part in supporting this vital element of public health care.
The panel – which also included Andrea Meisser, Vice-President of the Institute for Interdisciplinary Research on the Human-Animal Relationship, Ruud Tombrock, Director for the Europe Region of World Animal Protection, and Andrea Gavinelli, Head of Unit at the European Commission’s Health and food safety Directorate General – noted that while the benefits of the bond between people and pets are widely felt, they are sometimes hard to quantify empirically.
Professor Mills noted that it can be challenging for researchers to have papers accepted by journals or funding bodies, making it difficult for policymakers to promote the benefits of pets for public health. The panel agreed that greater partnership between all disciplines – from researchers to veterinarians and policymakers – was crucial to advancing the understanding of the public health benefits of pets and people.
Discussing how policymakers could play a part in promoting the One Health approach, Mr Gavanelli called on the pet care community to work together to provide scientific examples and data highlighting economic and social benefits. He also noted that policymakers in Europe had an important part to play by taking a holistic approach to the issue.
Professor Mills said: "The benefits of responsible pet ownership are clear. I’ve seen pets have dramatic effects on autistic children. Understanding the subtleties and nuances of how people and pets work together is vitally important for the well-being of both, and has the potential to make a massive difference to public health. But it is crucial that the industry is given an opportunity to analyse this further. Ignoring the evidence is a far greater problem than dismissing the research as being at an early stage."
Harper & Keele Veterinary School is a collaboration between Harper Adams University in Shropshire and Keele University in Staffordshire, and the BVetMS is the first UK veterinary degree to receive RCVS accreditation since the University of Surrey’s in 2019, as well as the first based in the West Midlands region.
Professor Tim Parkin FRCVS, RCVS President and Chair of the Education Committee (pictured right), said: “We would like to congratulate the staff at Harper & Keele Veterinary School for their hard work in ensuring that the school’s veterinary degree met our stringent accreditation standards, and welcome Harper & Keele graduates to their membership of the Royal College.
“Our accreditation panel found some very commendable aspects to the school, such as a commitment to inclusion and widening participation, how it supports students in finding non-clinical and clinical placements, and its use of innovation to support learning.
"We look forward to continuing to work with Harper & Keele over the coming months and years to ensure that high standards continue to be met.”
Professor Matt Jones MRCVS, an RCVS Council member and Head of School at Harper & Keele (pictured left), said: “We are delighted to receive the accreditation decision, which recognises our innovative approach to veterinary education and the huge commitment from our colleagues and partners that underpins it.
A Recognition Order to recognise the university’s degree will now be put before the Privy Council and, if it approves the Order, this will then be laid before Parliament.
If the Order is approved by both the Privy Council and Parliament, Harper & Keele’s degree will enter the cyclical RCVS accreditation process and be subject to annual monitoring.
The guides have been developed for vet teams to share with their clients and work through together, so that both sides are on the same page about owner values, pet welfare and behaviour, and diagnosis and treatment options.
A member of the veterinary team and the client can then work together to make decisions and provide quality care.
One of the pet owners who helped develop the guides said: “I always get so worked up with vet consultations that I forget half of what they say, or feel like I didn’t tell them enough about my pet’s history.
"If the vet used these guides at my next consult, they would make me feel very at ease indeed!”
Pam Mosedale, Clinical Lead at RCVS Knowledge, said: “These guides offer a simple, actionable way to help deliver contextualised care in practice.
"To get started, run through the questions in the guide with a client, and see how this can help you devise a treatment plan with the information you’ve discovered.
"This helps you gain a fuller understanding of your patient’s care and wellbeing needs and your client’s circumstances and expectations.
"Ultimately, this will assist you in delivering quality care that aligns with the needs and expectations of your clients.”
There are three contextualised care discussion guides:
RCVS Knowledge is encouraging veterinary teams to adapt the guides to meet their individual needs.
https://rcvsknowledge.org/contextualisedcare
COMMENT
Anything which helps clear communication between the owner and vet is surely to be applauded, and if owners are prepared to spend the time completing the pre-consultation guide, it would surely leave less room for error.
However, arguably the greatest cause of friction between owners and vets is cost, and that is something only mentioned fleetingly, in the context of: 'Are there any other factors that may impact on the care of your pet? e.g planned holidays or financial concerns'.
Isn't it time to stop beating around the bush?
Isn't there an opportunity here for greater clarity over the level of spending a client is happy with?
Is there an acceptable form of words here to ascertain whether - regardless of whether they have financial concerns or not - the client is one of those who wants the cheapest solution to the problem, one for whom money is no object, or someone who sits somewhere in the middle?
Wouldn't that be more instructive than almost anything else?
DISCUSS HERE
This, says the company, highlights a missed opportunity for earlier cancer detection, which in turn limits the ability of veterinary teams to improve medical outcomes for their patients.
243 veterinary professionals took part in the survey, most of whom HT Vista says were general practitioners.
On average, they reported seeing 13.5 dermal and subcutaneous masses per vet per week, less than six of which lead to a diagnosis.
HT Vista says around 15% of these lumps will be malignant.
Veterinary oncologist Gillian Dank said: “Every week, thousands of dogs leave practices with undiagnosed masses.
"While many are benign, others are malignant, and delaying diagnosis can mean lost treatment opportunities and poorer prognoses.”
The number one reason why respondents said they don't test more widely is the assumption that a mass is benign by its gross characteristics, followed by owner concerns around cost, time constraints during consultations, and limited access to in-house cytology.
Vista HT Chief Commercial Officer Asher Fink and Managing Director Liron Levy-Hirsch will be presenting “20 dogs in your waiting room with lumps and bumps – how do you spot the 3 with cancer?" at the London Vet Show on 20th November from 1–1:50pm in Exhibitor Showcase Theatre 2
https://info.ht-vet.com/lump-and-bump-survey-results
https://www.cliniciansbrief.com/continuing-education/syllabus/lesson/cracking-code-lumps-bumps-fast-efficient-diagnosis-everyday-practice
https://london.vetshow.com/conference-programme-2025/session-title-coming-soon-38
Photo: www.depositphotos.com
Virbac Animal Health is calling on practices to prepare for Canine Prostate Awareness Month (CPAM), being held by the company in November to highlight the prevalence of the disease and to encourage owners and practices to test for it.
Last year, 400 practices sign up to support the event, and the company says that feedback from many taking part confirmed a significant lack of understanding among clients as to the risk of prostate disease in dogs.
Canine Prostate Awareness Month is timed to coincide with 'Movember', when thousands of men grow moustaches to raise funds for male prostate and testicular cancer. During the month, Virbac is providing promotional materials including dog leads; educational and display materials and a press release for local media.
Chris Geddes MRCVS, Virbac Product Manager, said: "With more than 80% of entire male dogs over the age of five suffering from Benign Prostatic Hyperplasia (BPH)¹, we wanted to give practices a reason to highlight the risk and encourage owners to test for it. Timing CPAM to coincide with Movember seemed a good way to interest dog owners at a time when some might be considering the state of their own prostate.
"The support we received last year confirmed that it was a topic which practices were keen to discuss with dog owners so we're already planning to make the initiative even bigger and better this year."
Stephen Bamber, Principal at participating practice Warwickshire-based Avonvale Vets, added: "CPAM was an attractive campaign as it was a bit different. It offered the opportunity to see some of our older patients with other, less obvious pathologies. Non-symptomatic testicular tumours in particular surfaced in the checks we did. Clients generally had little idea about dogs' prostates so it gave us a good platform to discuss prostate disease with them."
Virbac has introduced OdelisTM CPSE, the first ELISA test to screen for, diagnose and monitor BPH, available from three UK diagnostic laboratories. The company says it's a cost-effective, precise and reliable alternative to rectal palpation. Virbac also offers Ypozane, a tablet treatment for BPH which takes effect within a week and lasts for up to six months.
Chris added: "BPH is an unpleasant condition occurring in nearly all entire dogs as they get older, but one which is entirely treatable. We hope that, by running our Prostate Awareness Campaign at a time when the media spotlight is already on the dangers of prostate cancer in men, we can help spread the message that owners should be monitoring older dogs for signs of prostate disease."
For further information on the Prostate Awareness Campaign, email cpam@virbac.co.uk; contact your Virbac Territory Manager or contact the company direct on 01359 243243.
References
The BVA has responded to the Written Ministerial Statement from the Defra Secretary of State at the end of the licence for badger culling in Somerset.
BVA President Robin Hargreaves said: "The British Veterinary Association (BVA) has supported the pilot culls in England to determine whether badger culling can be delivered humanely, effectively, and safely by controlled shooting.
"We will not prejudge the report of the Independent Expert Panel (IEP), which will consider data from the initial 6-week pilots in Somerset and Gloucestershire, but we are interested to note the Secretary of State's announcement that current indications suggest that the pilot has been safe and humane.
"Today our Veterinary Policy Group has discussed the issues surrounding the extensions to the licences. We agree with the Chief Veterinary Officer's advice that extensions in order to remove a greater number of badgers and get closer to achieving the 70% rate of the Randomised Badger Culling Trials (RBCTs) are justified to improve the bovine TB disease situation and mitigate the potential impact of badger perturbation.
"Following questions raised by our members we have been assured by Defra that monitoring of the culling will continue to ensure it is being carried out in accordance with the humaneness and safety stipulations in the licences. Although it is important to note that this data will not form part of the information being considered by the IEP.
"We await the report of the IEP and will engage members in considering what impact it will have on the overall bovine TB eradication strategy for England."
In response to growing demand for graduates equipped for a wide range of careers in veterinary and biomedical science, the Royal Veterinary College (RVC) has developed the BSc (Hons) course in Bioveterinary Sciences.
The Bioveterinary Science degree supersedes the BSc Veterinary Sciences that has been offered by RVC since 2002. Graduates go on to pursue careers within the biotechnology and pharmaceutical industries, veterinary-related professions, and biomedical research.
Prospective students interested in finding out more about the course are invited to attend an open day on Wednesday March 12 at the Camden Campus in London. Members of staff will be on hand to discuss aspects of the BSc in Bioveterinary Sciences degree, including entrance requirements and teaching and research facilities. In addition, current students will lead a tour of the London campus and talk about student life at the College. Further information and an online booking form can be found at http://www.rvc.ac.uk/
European Specialist in Veterinary Dentistry Lisa Milella, who revealed last year that she has been diagnosed with motor neurone disease, has now announced that she plans to end her life at the Swiss-based organisation, Dignitas, and is calling on MPs to support a Private Members Bill on assisted dying, due for a second reading next month.
Speaking to the Daily Mail, Lisa said: "In Britain, we give more dignity in death to our pets than we do human beings. I don't want to suffer a prolonged, lingering death. I want to be able to choose when I die – and I'd like to do that in my home, surrounded by my loved ones with dignity – but British law doesn't allow me to do that and that makes me angry."
Meanwhile, Lisa's campaign to raise money for International Animal Rescue has smashed its original target of £10,000 and now stands at £24,096.83, with a new target of £50,000.
Intervet/Schering-Plough has announced that Estrumate®, in both the 10ml and 20ml vial size is back in stock and available to order from your veterinary wholesaler.
The stock out situation had arisen as a result of increased demand during the early part of the year but the company is confident that there will be sufficient stock to supply the increased level of demand in the foreseeable future. Intervet/Schering-Plough would like to thank their clients for the patience and understanding.
Further information is available from Intervet/Schering-Plough Account Managers or the Veterinary Support Group (VSG) on 01908 685685.
Sogeval has launched Efex, a marbofloxacin tablet designed for veterinary use.
Efex tablets are available in three blister pack sizes of 10mg, 40mg and 100mg that break into halves for cats and halves and quarters for dogs, facilitating accurate dosing for a wide range of patients.
In cats, the flavoured chewable 10 mg tablets allow accurate dosing of 2.5kg and 5kg cats at 2mg/kg once daily. In dogs the 40mg four way break tablet is designed for a 20 kg dog and the 100mg for a 50kg dog.
Efex tablets are chewable and sogeval says that in a palatability study 7 out of 10 cats readily consumed them.
Each tablet contains a broad-spectrum fluoroquinolone antibiotic marbofloxacin for oral administration, which is readily absorbed reaching maximal plasma concentrations within two hours. It exhibits a wide range of activity against gram-negative and gram-positive bacteria, including Pseudomonas spp and Mycoplasma spp.
Norbrook Laboratories has produced a new pet owner advice booklet: The Guide to Safe Flea Treatment with the help of the Veterinary Poisons Information Service.
The booklet, which sits alongside a range of marketing materials to support Pestigon, the company's new spot on for cats and dogs, details the dangers of certain spot on products when used in the incorrect species, the risks of buying veterinary medicines online and the benefits of implementing a complete flea treatment program to treat the household and animal.
Michelle Jones, Norbrook's Small Animal Brand Manager said: "For pet owners, an infestation of fleas can be a nightmare. The Guide to Safe Flea Treatment has been produced to help pet owners, under the advice of their vet, understand the potential issues that could be faced with purchasing decisions when dealing with flea and tick infestations."
She added: "Pestigon was launched recently as a POM-V product and is sold exclusively through veterinary practices. The Guide to Safe Flea Treatment is available as part of a wider number of support materials available from Norbrook Laboratories including a useful waiting room display pack which will help support vets when prescribing the product and discussing flea treatments with their clients. "
The Guide to Safe Flea Treatment and other supporting materials are available through your Norbrook representative.
Bob Martin has launched FleaClear (fipronil) for cats and dogs, which will be sold through multiple retailers and leading pet retailers for as little as £4.50 per treatment.
The company says it is backing the launch with 'considerable marketing spend', which will include TV advertising, a press campaign in women's consumer lifestyle titles, PR and social media campaigns.
According to the company's press release: "Not only is it cheaper than Frontline it can be bought off the shelf saving a costly visit to the vets."
Indeed. Not to mention the savings to be made by not having to hospitalise the permethrined cat.
Vets Now has announced its selection centre dates for young vets applying for a place on the new 'Cutting Edge' Emergency and Critical Care fast track programme.
With the 20 August deadline for applications fast approaching, Vets Now has confirmed that interviews for the first intake in October will take place on 25th and 26th August. Applications received after this date will be considered only if the applicant meets the necessary criteria and is able to take up a place on the programme if extra places become available.
According to the company, the 'Cutting Edge' initiative is the first training programme of its kind in the UK. It'll see 40 vets who are likely to have graduated between 2006 and 2009 selected for a place on one of two 10 week fast track training programmes which will take them straight to the heart of emergency, working as a veterinary surgeon in a Vets Now clinic.
The induction courses will be held in October and January, each taking up to 20 vets through 10 weeks of intensive ECC training on a robust programme which has been designed by Vets Now Clinical Director and ECC Diplomate, Amanda Boag.
Amanda said: "The recruits who we select will embark upon an intensive period of training over the 10 week period which will give them the necessary skills and knowledge to launch their career in ECC. They will also receive ongoing support during their first two years as a Veterinary Surgeon in a Vets Now clinic with a very generous CPD allowance. The initial 10 week period will be a combination of lectures and interactive seminars, practical training in our clinical skills laboratory and mentored work in our clinics. Developing clinical expertise and problem solving skills will clearly be the most significant component of the training but there will also be support and training in other vital skills including communication."
She added: "Initial response to the programme has been very promising and we are delighted to see so many veterinary surgeons interested in developing their career in ECC."
Vets Now will continue to accept applications for the January intake to the 'Cutting Edge' programme throughout September and October.
Graduates who are interested in applying for a place on the 'Cutting Edge' training programme should contact the Vets Now recruitment team on 01383 841181 or email cuttingedge@vets-now.com
With Christmas just around the corner, Petplan is giving practices the chance to win £1,000 towards a Christmas party.
Any member of a practice can enter the competition by visiting www.petplanvet.co.uk.
Petplan Marketing Manager Alison Andrew said, "It's been another busy year for vet practices and we want to thank them for their tireless efforts to keep the nations pets full of health. The £1000 will allow them to really celebrate the festive season in style."
Veterinary staff can also enter the competition at the Petplan stand at the British Veterinary Nursing Association (BVNA) from 8th-10th October and at the London Vet Show on 22nd-23rd October 2010.
Petplan has opened nominations for its Petplan Insurance Advisor (PIA) of the Year award.
Available for staff at veterinary practices who are an Appointed Representative (AR) of Petplan, this award recognises PIA's who are dedicated to promoting the benefits of pet insurance in their practice.
Staff can nominate themselves or their colleagues via the website www.petplanvet.co.uk and are encouraged to provide examples of how the nominated PIA has improved practice performance.
The 2012 PIA of the Year will be crowned at the BVNA Congress on 6th October and the winner will receive an iPad. Submissions close on 20th September.
Simon Masding, Petplan Head of Sales and Partnerships said: "This award celebrates the fantastic job our PIAs do communicating the importance of pet insurance to their clients. We know first hand from the time we spend in practice, just how many fun, innovative ways they find to highlight how having insurance helps keep pets healthy."
Kruuse has announced the launch of two new two new wound dressing products: Kruuse HydroGel and Kruuse Foam Dressing.
Kruuse HydroGel is a clear amorphous hydrogel with Polyhexanide (0.04%). According to the company, HydroGel will help maintain a moist healing environment encouraging autolytic debridement and gentle removal of slough and necrotic tissue. It is presented as a single dose 15g applicator tube.
KRUUSE Foam Dressing is a non-adhesive; absorbent hydrophilic foam wound dressing coated with bacterial resistant micro porous thin foam backing. The company says it 'breathes' to allow oxygen in, expands as it absorbs exudate and conforms to shallow wound cavities. It is presented in 3 sizes: 5x5cm, 10x10cm and 15x15cm.
Andrew Groom , Managing Director, Kruuse UK Ltd. said: "Both products enhance the Kruuse's wound care product portfolio available to all customers, combined they increase the already extensive range of wound products available to the veterinary practitioner".
Both products will be on dispay and available at BSAVA 2013.
Royal Canin has announced the launch of two new veterinary diets designed to tackle obesity in cats and dogs.
'Satiety Small Dog' is for adult dogs with an ideal weight up to 10kg. 'Satiety Wet' has been developed for those dogs who prefer wet food, or who are used to eating a combination of wet and dry food.
Satiety Small Dog is available in 1.5kg, 3.5kg and 8kg bags and contains a blend of fibres that Royal Canin says increases the volume of stomach contents and promotes satiety. The company says the new diet also contains specific nutrients which contribute to maintaining good oral health, and a high protein content to help maintain muscle mass during the weight loss programme.
Satiety Small Dog is designed to improve digestive tolerance in smaller breeds, as it has a different blend of fibre and higher levels of butyrate than Satiety Canine, which is formulated for the needs of medium and larger dogs. The diet contains less dietary oxalate which Royal Canin claims is of benefit to smaller dogs that are at a greater risk of developing calcium oxalate uroliths.
The second new diet, Satiety Wet for Dogs, is available in 410g and 195g cans. The diet has a high protein content (14.1g per 100kcal), and is enriched with nutrients, minerals and vitamins. Royal Canin also highlights what it says is a particularly innovative feature: a high fibre content in a canned diet.
Ian Williams, Veterinary Scientific Support Manager at Royal Canin, said: "Almost 60% of dogs and 40% of cats in the UK and Ireland are overweight or obese. With obesity comes an increased risk of animals developing conditions affecting the upper respiratory tract, cardiopulmonary system, joints and urinary tract. In cats obesity is also a major risk factor for Type II diabetes mellitus. In essence, obesity can lead to a decreased life expectancy and a reduced quality of life.
"Royal Canin has a proven track record of developing innovative diets to help these pets and the latest additions to our range really will complement the existing choice for vets and their clients."
The RCVS is reminding veterinary surgeons to complete their registration process by confirming they have met the requirement for continuing professional development (CPD) and declared any outstanding convictions.
The College says that although the deadline for completing the annual renewal was April 2014, there are still some vets who, despite having paid on time, have not yet fully completed the registration process. This includes declaring that they have met the minimum requirement of 105 hours of CPD over a three-year period.
Failing to confirm that the CPD requirement has been met means that the College may request the individual's records as part of its annual monitoring of CPD compliance.
As of this year, veterinary surgeons must also declare any convictions, cautions and adverse findings since 1 January 2006 - or lack thereof - to complete the registration process.
Convictions disclosure forms and a document explaining the new protocol are available to download. The College also has a convictions helpline on 07818 113 056 which is open Monday to Friday, 11am to 4pm.
Those veterinary surgeons who have yet to complete their registration should contact the Registration Department as soon as possible on 020 7202 0707 or registration@rcvs.org.uk for assistance from a member of the team.
Talking to The Guardian, Hamaseh said: "This has really shocked me. We just discovered at the airport when we went to check in. I want people to know that this is not just happening to refugees. I am a graduate and I have a PhD. It has happened to a person who is working and who pays tax."
Hamaseh, who thought she'd have to find thousands of pounds to pay for an alternative flight home via another country, was quickly saved by a crowdfunding appeal by Women for Independence, which raised over £6000 in a matter of hours. The charity says it is donating everything in excess of the £2600 needed to get Hamaseh home to the Scottish Refugee Council.
Professor Anton Muscatelli, Principal of the University of Glasgow, said: "When I became aware on Saturday evening that one of our postgraduate veterinary students, Dr Hamaseh Tayari, was being prevented from travelling back from a holiday in Costa Rica through the United States and on to Glasgow I was both concerned and appalled. Concerned for the safety and well being of a young woman who, through no fault of her own, was stranded in Central America. Appalled because the reason for her predicament was not because she had done something wrong. Not because she was a danger to the security of the United States. But simply because she holds an Iranian passport."
He added: "Having spoken with Hamaseh I have been hugely impressed at how she is coping with the nightmare situation in which she finds herself. But I have been impressed too by the huge outpouring of support that has been shown across Scotland and the UK, particularly on twitter and through direct emails that have come in to the University from people who are outraged and want to help. All of this, I know, has greatly touched and heartened Hamaseh. I think it also confirms what we all like to believe is true. In this country we value individuals for what they are and the worth they bring, not for the stamp on their passport, the colour of their skin or the religion they practise."
Photo courtesy University of Glasgow
The RCVS is calling for comment on a proposed new Case Management Protocol for its Disciplinary Committee.
The new protocol provides additional guidance to all parties, ensuring that evidence is agreed or considered well before the hearing. Its emphasis is on the Committee being able to read skeleton arguments and bundles of evidence from respondents before the hearing takes place, which speeds up the process and enables decisions to be made more quickly. At present, this is not always possible, as the information is not always made available.
Gordon Hockey, Head of Professional Conduct said: "The new protocol formalises the standard procedural direction for cases to be heard by the Committee, with the aim of promoting the timely and efficient preparation of cases and the smooth running of hearings. This is in the interests of all parties."
The Disciplinary Committee hears between ten and 15 cases per year. Under the Veterinary Surgeons Act 1966, the Committee can consider charges of serious professional misconduct, fraudulent registration and criminal convictions that affect a veterinary surgeon's fitness to practise.
A disciplinary system for registered veterinary nurses was set up in April 2011 and the nurses' Disciplinary Committee would follow the new protocol, as and when it is finalised.
The proposed new Case Management Protocol can be downloaded from www.rcvs.org.uk/about-us/consultations. Comments are welcomed from members of the veterinary team and from the public, by Monday, 8 August 2011, and should be sent to Carrie Gage, Clerk to the Disciplinary Committee, on c.gage@rcvs.org.uk.
Pfizer Animal Health has launched a new range of diabetes support materials, including a DVD, post-prescription leaflet and home recording chart for owners of diabetic cats and dogs; a vet detailer, poster and blood glucose monitoring chart for the practice.
The company says that diabetes is on the increase in pets, as the level of obesity in cats and dogs escalates. Current estimates put the disease prevalence at 0.32% in the dog population1 with similar levels suggested for cats with some being as high as 1 in 1002. With increasing economic pressures and busy lifestyles, many owners are reluctant to take on the challenge of a diabetic pet, yet most pets respond extremely well to treatment.
Susan Mitchell, Insuvet® Product Manager at Pfizer Animal Health, believes that communication is key: "Helping owners to understand that treatment need not be difficult and that routines can be flexible enough to fit in with their lifestyles is critical. Time and time again it has been shown that cost is not always the primary consideration when it comes to treating the pet that is viewed as a much loved member of the family.
"Ensuring that owners understand exactly what will be expected of them is likely to be pivotal to the success of diabetes management than might first be assumed. Our new range of support material focuses on that need and takes the owner right the way through the process, from that initial diagnosis when decisions hang in the balance, to improving compliance by providing all the tools necessary for effective day to day management of the disease."
The new support materials include a DVD that explains all that clients need to know about the condition. This, says Pfizer, is the ideal choice after initial diagnosis, to reinforce and support the dialogue that takes place in the clinic environment. Shock, fear and confusion may mean that many owners will simply fail to take in all that their vet has to tell them after the initial diagnosis. This, in turn may prevent the owner from making an objective decision about their pet's future.
Once emotions have settled the client can watch the DVD in their own home, start to approach the future more rationally and decide what adaptations may have to be made. A post prescription leaflet is available to provide reassurance about the daily routine of monitoring a diabetic pet and a home recording chart to aid long-term compliance.
Of course, diabetic patients can be just as challenging in the practice environment so a comprehensive vet detailer is available along with blood glucose monitoring charts, a poster detailing what to do in a keto-acidotic emergency, a veterinary nurse discharging list and a clinic letter.
For further information on the Insuvet® range or to request support materials for diabetic clinics or individual patients, vets and nurses should contact their Pfizer Business Account Manager. For any technical questions about the Insuvet range call the Pfizer Animal Health Technical Support Line on 0845 3008034.
Defra has announced the detection of Bluetongue (Serotype 1) (BTV1) in five imported cattle on a premises near Blackpool in Lancashire.
The animals originated from within the BTV1 and 8 Restricted Zone in the south west of France and were detected as a result of post-import testing carried out by Defra on all Bluetongue susceptible animals arriving from continental Europe. The animals' documentation complied with the EU Bluetongue rules governing the movement of livestock as the movement occurred at least 60 days after they had been vaccinated.
This is the first case of BTV1 infection in the UK and the five animals have been culled as they may pose a disease threat to other animals. One further animal from the same consignment has also been culled. Test results for that animal were positive for bluetongue although it was not possible to determine the serotype.
There is no evidence that BTV1 is circulating in the UK and no additional control zones have been declared.
This response is in accordance with Defra's Bluetongue Control Strategy. The premises are now under restriction while an epidemiological investigation takes place. This will include further checks on the other animals present on the premises.
Chief Veterinary Officer Nigel Gibbens said: "This is the first case of BTV1 infected animals being imported into the UK. Taking into account the epidemiological evidence and the consideration of the risk represented to British livestock, I have taken the decision to cull these animals.
"This incident shows how important it is for farmers to consider potential disease risks when buying stock. Buyers need to consider how best to protect their own businesses and those of their neighbours and make sure they are clear about the stock they are intending to buy."
Defra continues to test all susceptible animals imported to the UK from continental Europe for all strains of Bluetongue and continues to urge industry to consider the risks and check the health and vaccination status of animals when sourcing any animals from within the UK or abroad.
In line with EU legislation, and our UK Control Strategy agreed with industry, control measures are in place in UK and abroad to prevent the spread of Bluetongue from existing zones around Europe:
Researchers at the Royal Veterinary College are seeking the help of veterinary surgeons in the UK who are treating dogs infected with Streptococcus zooepidemicus, a potentially fatal bacterial pneumonia-type disease which they say has been on the increase over the past five years.
The researchers are also trying to raise awareness of the signs of infection amongst vets and dog owners.
Streptococcus zooepidemicus is an infection that manifests itself similarly to human Toxic Shock Syndrome, causing a severe, bloody pneumonia in dogs. It has an acute onset and in a small proportion of cases the disease has been known to kill dogs within 24 hours of contracting the infection.
Outbreaks are sporadic, but particularly occur in situations where dogs mix in groups, such as rehoming or boarding kennels and in hunting and racing greyhound communities.
Although it is rarer in family pets, researchers are still keen to highlight the signs to owners, particularly if they regularly visit kennels or attend events where large groups of animals gather.
In the early stages, signs are similar to those of kennel cough, which is seen in similar environments. However, in Streptococcus zooepidemicus outbreaks, dogs rapidly become very ill and show very severe signs, with a mortality rate of up to 50% reported. In contrast to this, in more typical cases of kennel cough, most dogs will have a relatively mild illness and deaths are rare.
Researcher and veterinary pathologist Dr Simon Priestnall from the Royal Veterinary College said: "Although Streptococcus zooepidemicus was first identified in dogs in the 1970s, veterinarians and researchers have seen the number of cases spiral upwards over the past five years, particularly within rehoming kennels and the greyhound community. This suggests that the bacterium may have mutated to become more virulent and contagious.
"There is currently very limited public awareness of the problem. Signs for owners to look out for in their pets include a fever, which is usually accompanied by sneezing and nasal discharge which is often bloody, and their animal becoming lethargic. If owners notice the rapid onset of these signs, they are advised to seek veterinary help immediately. With prompt identification, medical treatment and supportive care, dogs can make a full recovery."
Dr Priestnall and his colleagues are working alongside the Animal Health Trust (Dr Andrew Waller) and the University of Nottingham School of Veterinary Medicine and Science (Drs Jenny Stavisky and Janet Daly) to investigate this potentially fatal bacterial pathogen.
They are developing a test that will allow them to determine, from a nasal or throat swab, how many dogs are suffering from the disease and how many are carriers. The hope is that by detecting patterns within the bacterial isolates or the infected dogs, they can uncover potential risk factors and limit the spread of the disease.
If you would like more information or to submit swab samples to help with the research into this disease, contact: spriestnall@rvc.ac.uk.